AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (December 15, 2006). doi:10.1152/ajpheart.01027.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/H2131    most recent
01027.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, D. D
Right arrow Articles by Durán, W. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, D. D
Right arrow Articles by Durán, W. N.
Submitted on September 19, 2006
Accepted on December 12, 2006

ENDOTHELIAL NITRIC OXIDE SYNTHASE IS A MOLECULAR VASCULAR TARGET FOR THE CHINESE HERB DANSHEN IN HYPERTENSION

David D Kim1*, Fabiola Alejandra Sanchez1, Ricardo Gabriel Duran1, Takehito Kanetaka2, and Walter N. Durán3

1 Pharmacology & Physiology, UMDNJ-New Jersey Medical School, Newark, New Jersey, United States
2 Newark, New Jersey, United States; Pharmacology & Physiology, UMDNJ-New Jersey Medical School, Newark, New Jersey, United States
3 Pharmacology and Physiology, MSB H-609, New Jersey Medical School, Newark, New Jersey, United States

* To whom correspondence should be addressed. E-mail: kimda{at}umdnj.edu.

Danshen, a Chinese herb, reduces hypertension in Oriental Medicine. We hypothesized that Danshen acts partially through endothelial nitric oxide synthase (eNOS) signaling mechanisms. We tested the hypothesis using tanshinone IIA, an active ingredient of Danshen, and the 2-kidney-1-clip renovascular (2K1C) hypertension model in hamsters. Oral tanshinone (50 µg/100g of body weight) reduced mean arterial pressure (MAP) from 161.2±6.9 to 130.0±7.8 mmHg (mean±SEM; p<0.05) in hypertensive hamsters. MAP in sham-operated hamsters was 114.3±9.2 mmHg. Topical tanshinone at 1 µg/ml and 5 µg/ml increased normalized arteriolar diameter from 1.00 to 1.25±0.08 and 1.57±0.11, and increased periarteriolar nitric oxide concentration from 87.1±11.3 nM to 146.9±23.1 nM (p<0.05) at 5 µg/ml in hamster cheek pouch. NG-monomethyl-L-arginine inhibited tanshinone-induced vasodilatation. Hypertension reduced eNOS protein relative to sham-operated control. Tanshinone prevented the hypertension-induced reduction of eNOS, and increased eNOS expression to levels higher than sham-operated control in hamster cheek pouch. Topical tanshinone increased normalized arteriolar diameter from 1.0 to 1.47±0.08 in the cremaster muscle of control mice and to 1.12±0.13 in cremasters of eNOS-knockout mice. In ECV 304 cells transfected with eNOS-green fluorescent protein, tanshinone increased eNOS protein expression 1.35±0.05 and 1.85±0.07 -fold above control after 5 min and 1 hr application, respectively. Tanshinone also increased eNOS phosphorylation 1.19±0.07 and 1.72±0.20 -fold relative to control after 5 min and 1 hr application. Our data provide a basis to understand the action of a Chinese herb used in alternative medicine. We conclude that eNOS stimulation is one mechanism by which tanshinone induces vasodilatation and reduces blood pressure.




This article has been cited by other articles:


Home page
Circ. Res.Home page
N. Sayed, D. D. Kim, X. Fioramonti, T. Iwahashi, W. N. Duran, and A. Beuve
Nitroglycerin-Induced S-nitrosylation and Desensitization of Soluble Guanylyl Cyclase Contribute to Nitrate Tolerance
Circ. Res., September 12, 2008; 103(6): 606 - 614.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.